News & Analysis on Clinical Trial Services & Contract Research And Development
Kendle has posted a sprightly 30 per cent increase in service revenues in the second quarter, bringing in $127m, well ahead of forecasts and providing further evidence of the buoyancy of the contract research market.
The gulf in rates of growth between emerging and established markets in the biotech active pharmaceutical ingredient (API) sector has been highlighted in a new report from the Chemical Pharmaceutical Generic Association (CPA).
in-PharmaTechnologist.com's round-up of developments in the pharmaceutical manufacturing space features news of TGA approval for Capsugel’s plant, Spain’s first therapeutic protein plant and Isogen setting up in Delaware.
Charles River Laboratories saw its operating income advance 16 per cent to $77m in the second quarter on strong demand for its research services division, and also announced a $53m deal to buy a German contract service organisation.
The US Food and Drug Administration (FDA) is seeking feedback from the pharmaceutical industry to develop the recommendations of the Nanotechnology Task Force.
Outsourcing-Pharma.com presents its periodic round-up of new appointments, employment moves and personnel news in the pharmaceutical contract services sector.